Question 1

What are the most cited papers from CuriRx (United States)?

Accepted Answer

The most cited paper from CuriRx (United States) is "An immunogenic personal neoantigen vaccine for patients with melanoma" (Patrick Alexander Ott et al., 2017), with 3,022 citations. Next come "Hardening and tanning of insect ootheca, egg cases, egg sac, chorion, and silk" (31) and "Characterization of Co-Formulated High-Concentration Broadly Neutralizing Anti-HIV-1 Monoclonal Antibodies for Subcutaneous Administration" (16).

Question 2

Which research topics does CuriRx (United States) publish most on?

Accepted Answer

By volume in 2022-now: Microbial infections and disease research, Reproductive tract infections research, Insect and Arachnid Ecology and Behavior and Bacterial Infections and Vaccines.

Question 3

Which fields of science does CuriRx (United States) work in?

Accepted Answer

In all years, 73% of research at CuriRx (United States) is in Life Sciences, 20% in Physical Sciences. Its largest fields are Biochemistry, Genetics and Molecular Biology (27%), Agricultural and Biological Sciences (20%), Immunology and Microbiology (20%). It does 1.5× the world's share of Life Sciences.

Question 4

Is CuriRx (United States)'s research output growing?

Accepted Answer

Output in 2022-2025 was 47% lower than in 2018-2021.